NEXR
Nexera Technologies Ltd.
NASDAQ: NEXR · CONSUMER CYCLICAL · INTERNET RETAIL
$2.43
+10.96% today
Updated 2026-04-30
Market cap
$1.77M
P/E ratio
—
P/S ratio
0.11x
EPS (TTM)
$-81.07
Dividend yield
—
52W range
$2 – $343
Volume
1.0M
WallStSmart proprietary scores
41
out of 100
Grade: D
Sell
Investment rating
8.0
Growth
A5.0
Quality
C+2.0
Profitability
F5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 31.50% QoQ
Risks
- Thin margins at -21.80%
- Negative free cash flow $-3.82M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $5.86M | $10.01M | $13.69M | $16.83M | $16.83M |
| Net income | $-2.20M | $-4.60M | $-7.80M | $-3.68M | $-935000.00 |
| EPS | — | — | — | — | $-81.07 |
| Free cash flow | $-4.88M | $-4.37M | $-6.35M | $-6.43M | $-3.82M |
| Profit margin | -37.57% | -45.94% | -57.01% | -21.85% | -21.80% |
Peer comparison
Smart narrative
Nexera Technologies Ltd. trades at $2.43. Our Smart Value Score of 41/100 indicates the stock is fair. TTM revenue stands at $16.83M. with profit margins at -21.80%.
Frequently asked questions
What is Nexera Technologies Ltd.'s stock price?
Nexera Technologies Ltd. (NEXR) trades at $2.43.
Is Nexera Technologies Ltd. overvalued?
Smart Value Score 41/100 (Grade D, Sell).
What is the price target of Nexera Technologies Ltd. (NEXR)?
The analyst target price is $—, representing NaN% downside from the current price of $2.43.
What is Nexera Technologies Ltd.'s revenue?
TTM revenue is $16.83M.
Company info
SectorCONSUMER CYCLICAL
IndustryINTERNET RETAIL
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.11x
ROE-44.90%
Beta1.57
50D MA$3.08
200D MA$33.64
Shares out0.00B
Float0.00B
Short ratio—
Avg volume1.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—